1. Seipel, Katja, Frey, Michèle, Nilius, Henning, Bacher, Ulrike, Pabst, Thomas. 2023. Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. In Current oncology (Toronto, Ont.), 30, 10463-10476. doi:10.3390/curroncol30120762. https://pubmed.ncbi.nlm.nih.gov/38132396/
2. Hsu, Joanne I, Dayaram, Tajhal, Tovy, Ayala, Takahashi, Koichi, Goodell, Margaret A. . PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. In Cell stem cell, 23, 700-713.e6. doi:10.1016/j.stem.2018.10.004. https://pubmed.ncbi.nlm.nih.gov/30388424/
3. . 2017. Prevalence and architecture of de novo mutations in developmental disorders. In Nature, 542, 433-438. doi:10.1038/nature21062. https://pubmed.ncbi.nlm.nih.gov/28135719/
4. Fons, Nathan R, Sundaram, Ranjini K, Breuer, Gregory A, Brenner, Charles, Bindra, Ranjit S. 2019. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. In Nature communications, 10, 3790. doi:10.1038/s41467-019-11732-6. https://pubmed.ncbi.nlm.nih.gov/31439867/
5. Lambros, Maryou B, Natrajan, Rachael, Geyer, Felipe C, Ashworth, Alan, Reis-Filho, Jorge S. 2010. PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 23, 1334-45. doi:10.1038/modpathol.2010.121. https://pubmed.ncbi.nlm.nih.gov/20543821/
6. Zhang, Linda, Hsu, Joanne I, Braekeleer, Etienne D, Vassiliou, George, Goodell, Margaret A. 2024. SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells. In eLife, 12, . doi:10.7554/eLife.91611. https://pubmed.ncbi.nlm.nih.gov/38896450/
智鼠故事 
